Procymate

Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.

Procymate
Clinical data
Routes of
administration		By mouth
ATC code
  • none
Identifiers
  • carbamic acid 1-cyclohexylpropyl ester
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC10H19NO2
Molar mass185.267 g·mol−1
3D model (JSmol)
  • CCC(C1CCCCC1)OC(=O)N
  • InChI=1S/C10H19NO2/c1-2-9(13-10(11)12)8-6-4-3-5-7-8/h8-9H,2-7H2,1H3,(H2,11,12) ☒N
  • Key:IGISNRIWPJVXDB-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References
  1. "Procymate". Bank of Automated Data on Drugs. VIDAL Drug Database. Archived from the original on 12 January 2008.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.